Cited by

• Long-term chemoprevention in patients with adenomatous polyposis coli: an observational study.

  Neuhann TM, Haub K, Steinke-Lange V, Morak M, Laner A, Locher M, Holinski-Feder E. Neuhann TM, et al. Fam Cancer. 2022 Oct;21(4):463-472. doi: 10.1007/s10689-022-00292-2. Epub 2022 May 16. Fam Cancer. 2022. PMID: 35570229
• Chemoprevention of colorectal cancer in Japan: a brief introduction to current clinical trials.

  Ishikawa H, Nakamura T, Kawano A, Gondo N, Sakai T. Ishikawa H, et al. J Gastroenterol. 2009;44 Suppl 19:77-81. doi: 10.1007/s00535-008-2286-2. Epub 2009 Jan 16. J Gastroenterol. 2009. PMID: 19148798
• Sodium salicylate and 5-aminosalicylic acid synergistically inhibit the growth of human colon cancer cells and mouse intestinal polyp-derived cells.

  Takakura H, Horinaka M, Imai A, Aono Y, Nakao T, Miyamoto S, Iizumi Y, Watanabe M, Narita T, Ishikawa H, Mutoh M, Sakai T. Takakura H, et al. J Clin Biochem Nutr. 2022 Mar;70(2):93-102. doi: 10.3164/jcbn.21-74. Epub 2021 Dec 18. J Clin Biochem Nutr. 2022. PMID: 35400827 Free PMC article.
• Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets.

  Paul A, Edwards J, Pepper C, Mackay S. Paul A, et al. Cells. 2018 Oct 20;7(10):176. doi: 10.3390/cells7100176. Cells. 2018. PMID: 30347849 Free PMC article. Review.
• Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial.

  Ishikawa H, Wakabayashi K, Suzuki S, Mutoh M, Hirata K, Nakamura T, Takeyama I, Kawano A, Gondo N, Abe T, Tokudome S, Goto C, Matsuura N, Sakai T. Ishikawa H, et al. Cancer Med. 2013 Feb;2(1):50-6. doi: 10.1002/cam4.46. Epub 2013 Feb 3. Cancer Med. 2013. PMID: 24133627 Free PMC article. Clinical Trial.